ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
As of Sept. 1, Bayer has legally and financially separated its MaterialScience division into a new firm named Covestro. The business will remain a Bayer subsidiary until mid-2016, when it will be floated on financial markets. Covestro, which had 2014 sales of about $14 billion, has been considerably less profitable than Bayer’s drug and agrochemical businesses in recent years. “Independence will enable us to bring our strengths to bear in global competition more quickly, effectively, and flexibly,” says Covestro CEO Patrick Thomas.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X